Evidence map›Paper›PMID 38259274›Full record

ReviewFrontiers in pharmacology2023

Ferroptosis: a new antidepressant pharmacological mechanism.

Guangheng Zhang, Shimeng Lv, Xia Zhong, Xiangyu Li, Yunhao Yi, Yitong Lu, Wei Yan, Jiamin Li, Jing Teng

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Guangheng ZhangDepartment of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Shimeng LvDepartment of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Xia ZhongDepartment of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Xiangyu LiWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yunhao YiCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Yitong LuDepartment of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Wei YanAffiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Jiamin LiAffiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Jing TengDepartment of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Shandong University of Traditional Chinese Medicine · CNAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence rate of depression, a mental disorder, is steadily increasing and has the potential to become a major global disability factor. Given the complex pathological mechanisms involved in depression, the use of conventional antidepressants may lead to severe complications due to their side effects. Hence, there is a critical need to explore the development of novel antidepressants. Ferroptosis, a newly recognized form of cell death, has been found to be closely linked to the onset of depression. Several studies have indicated that certain active ingredients can ameliorate depression by modulating the ferroptosis signaling pathway. Notably, traditional Chinese medicine (TCM) active ingredients and TCM prescriptions have demonstrated promising antidepressant effects in previous investigations owing to their unique advantages in antidepressant therapy. Building upon these findings, our objective was to review recent relevant research and provide new insights and directions for the development and application of innovative antidepressant strategies.

Indexed as

antidepressantsdepressionferroptosispharmacological mechanismtraditional Chinese medicine

Identifiers

PMID38259274
PMCPMC10800430
OpenAlexW4390665055

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.